EUVIMEDEUVIMED entdecken
Open Access

Experimental colitis-induced visceral hypersensitivity is attenuated by GABA treatment in mice

Michael S Gold, Emanuel Loeza-Alcocer iD

American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.03.2024 · 326 (3) · G252-G263

DOI: 10.1152/ajpgi.00012.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.03.2024. Verfasst von Michael S Gold und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States. Hauptthemen laut MEDLINE: Colitis, Colitis, Ulcerative. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Pfizer (Davis).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GABA treatment reduces the severity of colitis and inflammation and produces inhibition of visceral hypersensitivity in colon-inflamed mice. These results raise the promising possibility that GABA treatment may be an effective therapeutic strategy for the management of symptoms associated with colitis. However, clinical studies are required to corroborate whether this mouse-model data translates to human colon.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisColitis, UlcerativeHumansAnimalsMiceColonCytokinesInflammationDisease Models, AnimalBody WeightDextran SulfateMice, Inbred C57BL

Stichwörter der Autor:innen

GABAchemical colitogencytokinesinflammatory bowel diseasevisceral hypersensitivity

Substanzen

CytokinesDextran Sulfate

Autor:innen und Institutionen

  • Department of Neurobiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States.

ORCID-Profile: Emanuel Loeza-Alcocer

Förderung

  • NIDDK NIH HHS
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Pfizer (Davis)

Zitieren

APA

Gold, M. S., & Loeza-Alcocer, E. (2024). Experimental colitis-induced visceral hypersensitivity is attenuated by GABA treatment in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology, 326(3), G252-G263. https://doi.org/10.1152/ajpgi.00012.2023

Vancouver

Gold MS, Loeza-Alcocer E. Experimental colitis-induced visceral hypersensitivity is attenuated by GABA treatment in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2024;326(3):G252-G263. doi:10.1152/ajpgi.00012.2023

BibTeX
@article{Gold2024,
  author = {Gold, Michael S and Loeza-Alcocer, Emanuel},
  title = {Experimental colitis-induced visceral hypersensitivity is attenuated by GABA treatment in mice},
  journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
  year = {2024},
  volume = {326},
  number = {3},
  pages = {G252--G263},
  doi = {10.1152/ajpgi.00012.2023}
}
Kostenlos starten →